Bijul Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 9.41 M
- Company Age 33 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.70 Cr
- Revenue Growth 35.25%
- Profit Growth -208.96%
- Ebitda -87.34%
- Net Worth -0.03%
- Total Assets -0.30%
About Bijul Pharmachem
Bijul Pharmachem Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 May 1991 and has a history of 33 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 9.41 M.
The company has closed loans amounting to ₹4.70 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajiv Bohra, Shivam Bohra, and Ashutosh Bohra serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH1991PTC061679
- Company No.
061679
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 1991
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Bijul Pharmachem?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivam Bohra  | Director | 14-Feb-2020 | Current |
| Ashutosh Bohra | Director | 10-Feb-2023 | Current |
| Rajiv Bohra | Director | 12-Nov-1991 | Current |
Financial Performance of Bijul Pharmachem.
Bijul Pharmachem Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 35.25% increase. The company also saw a substantial fall in profitability, with a 208.96% decrease in profit. The company's net worth dipped by a decrease of 0.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bijul Pharmachem?
In 2021, Bijul Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shivalik Remedies Private LimitedRajiv Bohra is a mutual person
Julie (India) LtdRajiv Bohra and Shivam Bohra are mutual person
- Alliance Soaps Private Limited
Rajiv Bohra and Shivam Bohra are mutual person
- Chiranji Lal & Sons Pvt Ltd
Rajiv Bohra is a mutual person
- Bright Business Services Private Limited
Rajiv Bohra is a mutual person
- Julie (India) Marketing Private Limited
Rajiv Bohra and Shivam Bohra are mutual person
Charges (Loans)
₹0
₹4.70 Cr
Charges Breakdown by Lending Institutions
- Uco Bank : 4.00 Cr
- Uti Bank Limited : 0.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2005 | Uti Bank Limited | ₹7.00 M | Satisfied |
| 14 May 2004 | Uco Bank | ₹4.00 Cr | Satisfied |
How Many Employees Work at Bijul Pharmachem?
Unlock and access historical data on people associated with Bijul Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bijul Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bijul Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
